Akan, HamdiÖngören, ŞenizSaltoğlu, NeşeÇağatay, Arif AtahanArat, Mutlu ErsözKalayoğlu, Sevgi B.Demir, Ahmet Muzaffer2024-02-082024-02-082014-05-12Akalın, H. vd. (2014). "Recommendations for the treatment of invasive fungal infections in hematological malignancies: A critical review of evidence and Turkish Expert Opinion (TEO-1)". Turkish Journal of Hematology, 31(2), 111-120.1300-77771308-5263https://doi.org/10.4274/tjh.2014.0103https://jag.journalagent.com/tjh/pdfs/TJH_31_2_111_120.pdfhttps://hdl.handle.net/11452/39593The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematological malignancies and also changing treatment strategies have had a great impact in managing affected patients. The medical literature includes some important clinical studies that are being used as evidence for guidelines. The problem with these studies and the guidelines is that they are not very easy to interpret, they include controversial issues, and they are not easy to apply to every patient or country. This paper was designed to critically show the main problems associated with these approaches and provide important information that will help Turkish doctors to adopt them in daily clinical practice.eninfo:eu-repo/semantics/openAccessAntifungal treatmentInvasive fungal infectionEvidenceHematological malignanciesLiposomal amphotericin-bEfficacyPreemptive antifungal therapyVoriconazoleNeutropenic patientsAmbisomeEmpirical-treatmentFebrilePersistent feverHigh-riskHematologyArticle0003380946000012-s2.0-8490591211511112031225035667HematologyAntifungal Agents; Posaconazole; MicafunginAllogeneic stem cell transplantationAntifungal activityAntimicrobial therapyAntiviral therapyAspergillosisAutologous stem cell transplantationCandidemiaCandidiasisDrug efficacyEsophagus candidiasisFeasibility studyFebrile neutropeniaHematologic malignancyHigh risk patientHodgkin diseaseHumanMulticenter study (topic)Multiple myelomaMycosisMyelodysplastic syndromeNephrotoxicityNeutropeniaNonhodgkin lymphomaNonhumanPhase 1 clinical trial (topic)Phase 2 clinical trial (topic)PhysicianRandomized controlled trial (topic)ReviewSystemic mycosisAmphotericin b.Amphotericin b deoxycholateAmphotericin b lipid complexAntifungal agentCaspofunginEchinocandinGalactomannanTriazoleVoriconazole